found that the CD4+ T‐cell subtype T‐helper cells can interact with dendritic cells and be primed in tumor‐draining lymph nodes, which is important for harnessing the antitumor immune response of anti‐PD‐1 treatment. The gene discussed is CD4; the disease is neoplasm.